Gideon Kersten
Impact in
- Pharmaceutical Science top 0.1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Microbiology top 0.5%
- Bacterial Infections and Vaccines
Papers in
-
- Advancements in Transdermal Drug Delivery 25
- Microbiology 29
- Bacterial Infections and Vaccines 23
- Co-authors
- Wim JiskootDaan J.A. CrommelinJean‐Pierre AmorijJoke A. BouwstraBernard MetzJayesh A. KulkarniRein VerbekeLinde Schoenmaker
- Journals
- Vaccine (25 papers)Journal of Controlled Release (9 papers)Pharmaceutical Research (9 papers)Biologicals (7 papers)PLoS ONE (7 papers)
- Partner nations
- NetherlandsUnited StatesGuinea-Bissau
In The Last Decade
Gideon Kersten
124 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Pharmaceutical Science 1.7k
- Microbiology 705
- Immunology 1.8k
- Dermatology 610
- Infectious Diseases 1.1k
Countries citing papers authored by Gideon Kersten
This map shows the geographic impact of Gideon Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gideon Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gideon Kersten more than expected).
Fields of papers citing papers by Gideon Kersten
This network shows the impact of papers produced by Gideon Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gideon Kersten. The network helps show where Gideon Kersten may publish in the future.
Co-authors
The 25 scholars most cited alongside Gideon Kersten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 18 | |
| 4 | 2020 | 41 | |
| 5 | 2019 | 11 | |
| 6 | 2018 | 45 | |
| 7 | 2017 | 4 | |
| 8 | 2017 | 69 | |
| 9 | 2016 | 18 | |
| 10 | 2016 | 53 | |
| 11 | 2015 | 4 | |
| 12 | Original Research Nano-adjuvanted polio vaccine: Preparation and characterization of chitosan and trimethylchitosan (TMC) nanoparticles loaded with inactivated polio virus and coated with sodium alginate | 2014 | 3 |
| 13 | 2013 | 34 | |
| 14 | 2012 | 47 | |
| 15 | 2010 | 33 | |
| 16 | 2007 | 55 | |
| 17 | 2005 | 30 | |
| 18 | 2003 | 117 | |
| 19 | 2003 | 10 | |
| 20 | 2000 | 29 |
About Gideon Kersten
Gideon Kersten is a scholar working on Pharmaceutical Science, Microbiology, Immunology, Dermatology and Infectious Diseases, having authored 125 papers that have together received 6.3k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (26 papers), Advancements in Transdermal Drug Delivery (25 papers), Immunotherapy and Immune Responses (23 papers), Bacterial Infections and Vaccines (23 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Viral Infections and Immunology Research (18 papers), Influenza Virus Research Studies (16 papers) and Dermatology and Skin Diseases (16 papers). The work is most often cited by research in Pharmaceutical Science (1.7k citations), Microbiology (705 citations), Immunology (1.8k citations), Dermatology (610 citations) and Infectious Diseases (1.1k citations). Gideon Kersten has collaborated with scholars based in Netherlands, United States and Guinea-Bissau. Frequent co-authors include Wim Jiskoot, Daan J.A. Crommelin, Jean‐Pierre Amorij, Joke A. Bouwstra, Bernard Metz, Jayesh A. Kulkarni, Rein Verbeke, Linde Schoenmaker, Dominik Witzigmann and Peter C. Soema. Their work appears in journals such as Vaccine, Journal of Controlled Release, Pharmaceutical Research, Biologicals and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.